Free Trial
→ The 1934 playbook (From American Alternative) (Ad)tc pixel Free LCTX Stock Alerts

Lineage Cell Therapeutics (LCTX) Earnings Date, Estimates & Call Transcripts

Lineage Cell Therapeutics logo
$1.23 +0.02 (+1.24%)
Closing price 03:59 PM Eastern
Extended Trading
$1.22 0.00 (-0.33%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Lineage Cell Therapeutics Earnings Summary

Lineage Cell Therapeutics posted Q1 2026 earnings on May 12, 2026, reporting an EPS of -$0.03, which missed analysts' consensus estimates of -$0.02 by $0.01. Quarterly revenue was reported to be $1.73 million, below the consensus estimate of $3.60 million. With a trailing EPS of -$0.12, Lineage Cell Therapeutics' earnings are expected to grow next year, from ($0.07) to ($0.05) per share.

Upcoming Q2
Earnings Date
Aug. 11After Market ClosesEstimated
Consensus EPS
(May. 12)
-$0.02
Actual EPS
(May. 12)
-$0.03 Missed By -$0.01
Actual Revenue
(May. 12)
$1.73M

Q1 2026 Earnings Resources

LCTX Upcoming Earnings

Lineage Cell Therapeutics' next earnings date is estimated for Tuesday, August 11, 2026, based on past reporting schedules.

Powered by Quartr
Get Lineage Cell Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lineage Cell Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LCTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LCTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lineage Cell Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261-$0.02-$0.02-$0.02
Q4 20261$0.00$0.00$0.00

Lineage Cell Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026
(Estimated)		--------
5/12/2026Q1 2026-$0.02-$0.03 -$0.01-$0.03$3.60M$1.73M
3/5/2026Q4 2025-$0.07$0.0040+$0.0740$0.0040$1.96M$6.61M
11/6/2025Q3 2025-$0.02-$0.13 -$0.11-$0.13$2.30M$3.68M
8/8/2024--$0.04-$0.03+$0.01-$0.03$1.28M$1.41M

Data powered by Fiscal.ai.

Lineage Cell Therapeutics Earnings - Frequently Asked Questions

Lineage Cell Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 11th, 2026 based off last year's report dates. Learn more on LCTX's earnings history.

In the previous quarter, Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) missed the analysts' consensus estimate of ($0.02) by $0.01 with a reported earnings per share (EPS) of ($0.03). Learn more on analysts' earnings estimate vs. LCTX's actual earnings.

The conference call for Lineage Cell Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Lineage Cell Therapeutics' latest earnings report can be read online.
Read Transcript

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded annual revenue of $14.56 million.

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded net income of -$63.53 million. LCTX has generated -$0.12 earnings per share over the last four quarters.

Lineage Cell Therapeutics' earnings are expected to grow from ($0.07) per share to ($0.05) per share in the next year.

Related Companies
Earnings Tools

This page (NYSEAMERICAN:LCTX) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel